Your Recent Quotes: 0 | 0

Schering-Plough Corporation

Related Information and Financials
Price Glossary Definition
20.39
-1.50%
8/20/08 2:53
Open
20.71
Prev Close
20.70
Volume
7,881,679
52 Wk. Range
14-33
Year-to-Date Performance Glossary Definition
Latest Dividend
Dividend
0.06
Yield
1.28
Ex-Date
07/30/2008
Price/Earnings Comparisons Glossary Definition
 
-15.07
 
0.00
 
20.20
SGP
Sect. Av.
S&P 500
Market Cap
33,080,797,200
Outstanding Shares
1,621,354,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy SGP Rating Report
Target Price (1Yr)
High
37.00
Revenue
19.04B

Annual Dividend
Rate
0.26
Yield
1.30
Growth
12 Month
3 Year
CAGR
Revenue
19.80
0.53
0.15
Net Income
-100.00
0.56
0.00
EPS
-100.00
0.55
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
6.54
-29.01
-4.83
Earnings Per Share($)

12/2005
 
 
 
0.12
12/2006
 
 
 
0.69
12/2007
 
 
 
-1.04

Earnings
EBITDA
752,000,000
Revenue
12.69B
Outside Analyst Rating History

8/20/08
9
Buy
8/20/08
4
Hold
8/20/08
0
Sell

Jim Cramer Portfolio
Find out now if SGP is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
  • S&P 500 (SPX.X)
  • Dow Jones (INDU)
  • Nasdaq (COMPX)
    Latest Headlines
    The drugmakers reached a deal with U.S. and European regulators to start the new phase II study for the hepatitis treatment.

    8:33PM 08/18/08

    Regulators warn of two deaths possibly related to its diabetes drug.

    4:26PM 08/18/08

    The company plans to rely on the sales of other drugs, particularly in overseas markets.

    5:38PM 08/13/08

    A single patient's allergic reaction may have delayed U.S. approval by up to three years.

    10:10AM 08/13/08

    Catch up on his thinking on the hottest topics of the past week.

    10:00AM 08/09/08

    Health stocks higher to close the week, Gilead reaches 52-week high.

    5:08PM 08/08/08

    Having a broker lose my money taught me that I needed to master the fundamentals of trading like I did baseball.

    11:53AM 08/07/08

    Shares of the biopharmaceutical company slid after it posted a widened quarterly loss and slashed staff.

    5:07PM 08/05/08

    Pharmaceutical makers outpaced biotech stocks on Monday.

    4:50PM 08/04/08

    Biogen sinks on Tysabri-related news.

    5:06PM 08/01/08

    Understanding the Market

    Our Experts' Take at RealMoney
    The lack of fear in the markets, despite a wealth of bad news, may be bad news itself.

    7:03AM 08/20/08

    The stock appears to be forming a base, but be cautious about stop placement.

    2:00PM 08/18/08

    More Experts' Takes


    Premium Stock Ideas